recombinant lentiviral gene vector-based therapeutic vaccine (THERAVECTYS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant lentiviral gene vector-based therapeutic vaccine (THERAVECTYS)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheravectys Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheravectys Sa
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A